A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular complications-Reference-Cited by-同舟云学术

A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular complications

Published:2010-07-15 Issue:9 Volume:24 Page:1574-1579
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Passamonti F,Rumi E,Pietra D,Elena C,Boveri E,Arcaini L,Roncoroni E,Astori C,Merli M,Boggi S,Pascutto C,Lazzarino M,Cazzola M

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2010148.pdf

Reference43 articles.

1. Tefferi A, Vardiman JW . Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia 2008; 22: 14–22.

2. Cervantes F, Passamonti F, Barosi G . Life expectancy and prognostic factors in the classic BCR/ABL-negative myeloproliferative disorders. Leukemia 2008; 22: 905–914.

3. Passamonti F, Rumi E, Caramella M, Elena C, Arcaini L, Boveri E et al. A dynamic prognostic model to predict survival in post-polycythemia vera myelofibrosis. Blood 2008; 111: 3383–3387.

4. Marchioli R, Finazzi G, Landolfi R, Kutti J, Gisslinger H, Patrono C et al. Vascular and neoplastic risk in a large cohort of patients with polycythemia vera. J Clin Oncol 2005; 23: 2224–2232.

5. Gangat N, Strand J, Li CY, Wu W, Pardanani A, Tefferi A . Leucocytosis in polycythaemia vera predicts both inferior survival and leukaemic transformation. Br J Haematol 2007; 138: 354–358.

Cited by 308 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic Performance of Serum Erythropoietin to Discriminate Polycythemia Vera from Secondary Erythrocytosis through Established Subnormal Limits;Diagnostics;2024-08-29

2. Prevention of ischemic stroke in patients with myeloproliferative neoplasms;Russian journal of hematology and transfusiology;2024-08-18

3. Association between JAK2V617F variable allele frequency and risk of thrombotic events in patients with myeloproliferative neoplasms;Irish Journal of Medical Science (1971 -);2024-08-14

4. Cardiovascular Risk in Philadelphia-Negative Myeloproliferative Neoplasms: Mechanisms and Implications—A Narrative Review;Current Issues in Molecular Biology;2024-08-02

5. Polycythemia vera: past, present and future;Leukemia & Lymphoma;2024-06-13